Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy.
Zhang Y, Gabere M, Taylor MA, Simoes CC, Dumbauld C, Barro O, Tesfay MZ, Graham AL, Ferdous KU, Savenka AV, Chamcheu JC, Washam CL, Alkam D, Gies A, Byrum SD, Conti M, Post SR, Kelly T, Borad MJ, Cannon MJ, Basnakian A, Nagalo BM. Zhang Y, et al. Among authors: tesfay mz. Front Oncol. 2022 Nov 9;12:1042250. doi: 10.3389/fonc.2022.1042250. eCollection 2022. Front Oncol. 2022. PMID: 36457491 Free PMC article.
Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine.
Peng KW, Carey T, Lech P, Vandergaast R, Muñoz-Alía MÁ, Packiriswamy N, Gnanadurai C, Krotova K, Tesfay M, Ziegler C, Haselton M, Sevola K, Lathrum C, Reiter S, Narjari R, Balakrishnan B, Suksanpaisan L, Sakuma T, Recker J, Zhang L, Waniger S, Russell L, Petro CD, Kyratsous CA, Baum A, Janecek JL, Lee RM, Ramachandran S, Graham ML, Russell SJ. Peng KW, et al. Among authors: tesfay m. Vaccine. 2022 Apr 1;40(15):2342-2351. doi: 10.1016/j.vaccine.2021.12.063. Epub 2022 Jan 10. Vaccine. 2022. PMID: 35282925 Free PMC article.
Blinded rechecking of sputum smear microscopy performance in public health facilities in Tigray region, Northern Ethiopia: Retrospective cross sectional study.
Weldemhret L, Hailu A, Gebremedhn G, Bekuretsion H, Alemseged G, Gebreegziabher G, Tesfahuney G, Berhe T, Legesse L, Kalayu K, Tesfay M, Mehari K. Weldemhret L, et al. Among authors: tesfay m. PLoS One. 2020 Oct 7;15(10):e0239342. doi: 10.1371/journal.pone.0239342. eCollection 2020. PLoS One. 2020. PMID: 33027314 Free PMC article.
Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2.
Vandergaast R, Carey T, Reiter S, Lech P, Gnanadurai C, Tesfay M, Buehler J, Suksanpaisan L, Naik S, Brunton B, Recker J, Haselton M, Ziegler C, Roesler A, Mills JR, Theel E, Weaver SC, Rafael G, Roforth MM, Jerde C, Tran S, Diaz RM, Bexon A, Baum A, Kyratsous CA, Peng KW, Russell SJ. Vandergaast R, et al. Among authors: tesfay m. bioRxiv [Preprint]. 2020 May 27:2020.05.26.117549. doi: 10.1101/2020.05.26.117549. bioRxiv. 2020. PMID: 32577655 Free PMC article. Updated. Preprint.
Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers.
Suksanpaisan L, Xu R, Tesfay MZ, Bomidi C, Hamm S, Vandergaast R, Jenks N, Steele MB, Ota-Setlik A, Akhtar H, Luckay A, Nowak R, Peng KW, Eldridge JH, Clarke DK, Russell SJ, Diaz RM. Suksanpaisan L, et al. Among authors: tesfay mz. Mol Ther Oncolytics. 2018 Jul 5;10:1-13. doi: 10.1016/j.omto.2018.05.001. eCollection 2018 Sep 28. Mol Ther Oncolytics. 2018. PMID: 29998190 Free PMC article.
17 results